Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Doxycycline is the active ingredient of these drugs:
United States
Hong Kong
Canada
Canada
Italy
Hong Kong
Ireland
Brazil
South Africa
Australia United States
Spain
Austria
Germany
Tunisia
Cyprus
Spain
Brazil
South Africa
Finland
Finland
New Zealand
Spain
Hong Kong South Africa
Spain
Finland Lithuania
Australia
France Hong Kong New Zealand United States
Estonia
Austria
Hong Kong Singapore
Hong Kong
South Africa
South Africa
Austria
Germany
Austria
Estonia Germany South Africa
Estonia
Australia
Singapore
France
Hong Kong Singapore South Africa
Hong Kong
France
Canada
South Africa
Ireland Netherlands Poland United Kingdom
Australia
France
Ecuador
Austria Poland Spain
United States
Cyprus Hong Kong Singapore
Singapore
Italy
United States
Tunisia
United States
United States
Ecuador Finland Spain United States
Austria Estonia
Canada United Kingdom
Spain
South Africa
Cyprus Hong Kong
Spain
France
Hong Kong
United States
Singapore Tunisia
South Africa
France Hong Kong
Poland
Tunisia
Spain
Brazil
Mexico
Austria Cyprus Hong Kong Ireland Netherlands
Tunisia
France
Austria
Spain